Award Information
Award #
2011-DN-BX-K559
Funding Category
Competitive
Awardee County
Miami-Dade
Congressional District
Status
Closed
Funding First Awarded
2011
Total funding (to date)
$143,225
Description of original award (Fiscal Year 2011, $143,225)
This project will determine the cross-reactivity, false-positive rate, and false-negative rate for a broad range of designer drugs in commercially available screening immunoassays. Studies will focus on ante-mortem blood specimens using ELISA-based assays and urine specimens using EMIT-based assays.
ca/ncf
Date Created: August 23, 2011
Similar Awards
- Fostering Diversity in a Police Agency, From Bottom to Top
- Non-contact detection of fentanyl and other synthetic opioids: Towards a generalized approach to the detection of dangerous drug clases
- Improving Outcomes for Child Sex Trafficking Victims, Phase 2: A Rigorous Outcome Evaluation of Love146’s Long-Term Services (LTS) Program